Evidence map›Paper›PMID 24860842›Full record

ArticleJournal of cardiovascular disease2014

Gene Deletion of VIP Leads to Increased Mortality Associated with Progressive Right Ventricular Hypertrophy.

Anthony M Szema, Sayyed A Hamidi

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in Journal of cardiovascular disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Emerging Novel Therapies for Heart Failure.Clinical Medicine Insights. Cardiology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Anthony M SzemaDepartment of Medicine, Stony Brook University School of Medicine, 11794 Stony Brook, NY (AMS, SAH); Allergy Section, Veterans Affairs Medical Center, 11768 Northport, NY, (AMS); Three Village Allergy & Asthma, PLLC, 11720 South Setauket, NY, (AMS); Research, Veterans Affairs Medical Center, 11768 Northport, NY, USA (SAH).
Sayyed A HamidiDepartment of Medicine, Stony Brook University School of Medicine, 11794 Stony Brook, NY (AMS, SAH); Allergy Section, Veterans Affairs Medical Center, 11768 Northport, NY, (AMS); Three Village Allergy & Asthma, PLLC, 11720 South Setauket, NY, (AMS); Research, Veterans Affairs Medical Center, 11768 Northport, NY, USA (SAH).
Veterans Health Administration · US

Funding

Bronchodilation &Anti-Inflammatory Response by VIPK08HL071263 · NHLBI · STATE UNIVERSITY NEW YORK STONY BROOK · PI SZEMA, ANTHONY M · 2004 to 2008
$703k
Effects of Hurricane Sandy on the Respiratory and Mental Health of WTC RespondersR21ES023583 · NIEHS · STATE UNIVERSITY NEW YORK STONY BROOK · PI GONZALEZ, ADAM · 2013 to 2014
$388k
NHLBI NIH HHS K08 HL071263NIEHS NIH HHS R21 ES023583
6 · The paper itself

Abstract

Vasoactive Intestinal Peptide (VIP) knockout mice exhibit asthma, pulmonary hypertension, and left ventricular wall thinning. Humans with these disorders have premature death. We show here that VIP KO mice have reduced survival (100% mortality at 20 months),

Indexed as

asthmaknockout micepulmonary hypertensionright heart failureVasoactive Intestinal PeptideVIP

Identifiers

PMID24860842
PMCPMC4031245
OpenAlexW2107207385

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.